Germline (g)BRCA1/2 mutations (m) and hematological toxicities in patients (pts) with triple negative breast cancer (TNBC) treated with neoadjuvant chemotherapy (NACT)

首页> 外文期刊>Intelligence: A Multidisciplinary Journal >Germline (g)BRCA1/2 mutations (m) and hematological toxicities in patients (pts) with triple negative breast cancer (TNBC) treated with neoadjuvant chemotherapy (NACT)

【24h】

Germline (g)BRCA1/2 mutations (m) and hematological toxicities in patients (pts) with triple negative breast cancer (TNBC) treated with neoadjuvant chemotherapy (NACT)

机译：用新辅助化疗治疗（NACT）治疗（NACT）治疗的患者（PTS）中的种系（G）BRCA1 / 2突变（M）和血液毒性（TNBC）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Intelligence: A Multidisciplinary Journal 》 |2020年第2020期| 共4页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心理学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Germline (g)BRCA1/2 mutations (m) and hematological toxicities in patients (pts) with triple negative breast cancer (TNBC) treated with neoadjuvant chemotherapy (NACT) [J] . Intelligence: A Multidisciplinary Journal . 2020 ,第期

机译：用新辅助化疗治疗（NACT）治疗（NACT）治疗的患者（PTS）中的种系（G）BRCA1 / 2突变（M）和血液毒性（TNBC）
2. NEOTALA: an open-label, single-arm, multi-center, phase 2 study of talazoparib for neoadjuvant treatment of germline BRCA1/2 mutation patients with early-stage triple negative breast cancer (TNBC) [J] . Litton J., Symmans F., Gogineni K., The Breast : . 2019 ,第期

机译：Neotala：开放标签，单臂，多中心，第2期关于塔罗扎里布的Neoadjuvant治疗针对种系BRCA1 / 2突变患者的早期三重阴性乳腺癌（TNBC）
3. NEOTALA: an open-label, single-arm, multi-center, phase 2 study of talazoparib for neoadjuvant treatment of germline BRCA1/2 mutation patients with early-stage triple negative breast cancer (TNBC) [J] . Litton J., Symmans F., Gogineni K., The Breast : . 2019 ,第Suppla1期

机译：Neotala：开放标签，单臂，多中心，第2期关于塔罗扎里布的Neoadjuvant治疗针对种系BRCA1 / 2突变患者的早期三重阴性乳腺癌（TNBC）
4. TNF siRNA as Modulators of Apoptosis and Angiogenesis, in Cell Migration and Invasion in Triple Negative Breast Cancer Cells (TNBC) [C] . Ioana Berindan Neagoe, Valentina Pileczki, Roxana Cojocneanu Petric, Molecular Medicine TRI-CON. . 2014

机译：TNF siRNA作为细胞凋亡和血管生成的调节剂，在三重阴性乳腺癌细胞中的细胞迁移和侵袭中（TNBC）
5. The Attenuating Effects of 1,2,3,4,6-Penta-O-Galloyl-β-D Glucose (PGG) on the Inflammatory Cytokines Release in TNF-α-activated Triple Negative Breast Cancer (TNBC) Cells [D] . Alghamdi, Sumiah. 2019

机译：1,2,3,4,6-五核苷酸-β-D葡萄糖（PGG）对TNF-α-活化的三阴性乳腺癌（TNBC）细胞炎症细胞因子释放的衰减效应
6. A randomized phase II neoadjuvant study of cisplatin paclitaxel with or without everolimus in patients with stage II/III triple-negative breast cancer (TNBC): Responses and long-term outcome correlated with increased frequency of DNA damage response gene mutations TNBC subtype AR status and Ki67 [O] . Bojana Jovanović, Ingrid A. Mayer, Erica L. Mayer, -1

机译：II / III期三阴性乳腺癌（TNBC）患者的顺铂紫杉醇联合或不联合依维莫司的II期随机新阶段随机研究：反应和长期预后与DNA损伤反应基因突变TNBC亚型 AR状态和Ki67
7. Faculty Opinions recommendation of A Randomized Phase II Neoadjuvant Study of Cisplatin, Paclitaxel With or Without Everolimus in Patients with Stage II/III Triple-Negative Breast Cancer (TNBC): Responses and Long-term Outcome Correlated with Increased Frequency of DNA Damage Response Gene Mutations, TNBC Subtype, AR Status, and Ki67. [O] . Sherene Loi 2019

机译：大学意见建议的Cisplatin，紫杉醇的随机阶段II Neoadjuvant研究，患者II / III三重阴性乳腺癌（TNBC）的患者（TNBC）：与DNA损伤响应基因突变的增加频率相关的反应和长期结果相关，TNBC子类型，AR状态和ki67。

Germline (g)BRCA1/2 mutations (m) and hematological toxicities in patients (pts) with triple negative breast cancer (TNBC) treated with neoadjuvant chemotherapy (NACT)

著录项

相似文献

相关主题

期刊订阅